Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,888
Closed -$304K 216
2025
Q4
$304K Sell
2,888
-1,756
-38% -$165K 0.05% 174
2025
Q3
$390K Buy
4,644
+213
+5% +$17.5K 0.07% 161
2025
Q2
$351K Buy
4,431
+33
+0.8% +$2.62K 0.07% 175
2025
Q1
$395K Buy
4,398
+324
+8% +$30.3K 0.07% 189
2024
Q4
$405K Buy
4,074
+223
+6% +$23K 0.07% 185
2024
Q3
$437K Buy
3,851
+316
+9% +$37.5K 0.08% 180
2024
Q2
$438K Buy
3,535
+127
+4% +$16.4K 0.09% 179
2024
Q1
$450K Buy
3,408
+314
+10% +$38.7K 0.09% 180
2023
Q4
$392K Buy
3,094
+189
+7% +$19.6K 0.08% 184
2023
Q3
$299K Buy
2,905
+35
+1% +$3.77K 0.07% 182
2023
Q2
$331K Buy
2,870
+297
+12% +$33.7K 0.07% 175
2023
Q1
$274K Hold
2,573
0.07% 173
2022
Q4
$285K Hold
2,573
0.07% 183
2022
Q3
$222K Hold
2,573
0.06% 164
2022
Q2
$235K Sell
2,573
-11
-0.4% -$975 0.06% 159
2022
Q1
$212K Buy
+2,584
New +$204K 0.05% 195
2021
Q3
Sell
-3,627
Closed -$282K 185
2021
Q2
$282K Sell
3,627
-146
-4% -$10.9K 0.07% 152
2021
Q1
$278K Hold
3,773
0.08% 144
2020
Q4
$294K Buy
+3,773
New +$289K 0.09% 111

Other funds holding MRK

PAX Financial Group's MRK Position: Q1 2026 in Review

PAX Financial Group sold out of Merck (MRK) in Q1 2026, closing a stake of 2,888 shares — an estimated $304K sold.

PAX Financial Group first reported a position in MRK in Q4 2020 and held it in 19 quarters. The position peaked at $450K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • PAX Financial Group reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • PAX Financial Group sold 2,888 Merck shares in Q1 2026, an estimated $304K.
  • PAX Financial Group first reported a position in Merck in Q4 2020 and held it in 19 quarters.
  • PAX Financial Group's Merck position peaked at $450K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on PAX Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.